Pifexole
CAS: 27199-40-2
Ref. 3D-CBA19940
| 1g | Nachfragen | ||
| 5g | Nachfragen | ||
| 10g | Nachfragen | ||
| 250mg | Nachfragen | ||
| 500mg | Nachfragen |
Produktinformation
Pifexole is a potent anticancer drug that acts as an inhibitor of cyclin-dependent kinases (CDKs) and protein kinase B (AKT). This drug has been shown to induce apoptosis in cancer cells and inhibit tumor growth. Pifexole is derived from a Chinese medicinal plant, and its analog has been found in human urine. It targets CDKs and AKT, which are involved in the regulation of cell cycle progression and survival, respectively. Pifexole inhibits these enzymes, leading to cell death and preventing further growth of cancer cells. This drug has shown promising results in preclinical studies for various types of cancers, including breast, lung, and prostate cancer. Additionally, Pifexole has minimal toxicity compared to other anticancer drugs currently available on the market. Overall, Pifexole is a promising new therapy for cancer treatment with potential for significant impact on patient outcomes.
Chemische Eigenschaften
Technische Anfrage zu: 3D-CBA19940 Pifexole
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
